ILLUMINA, INC. (ILMN)
About ILLUMINA, INC.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $4.3B
- Net income
- $850.0M
- Total assets
- $6.6B
- Market cap
- $29.4B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $29.4B
- Shares outstanding
- 108.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 28, 2000
Illumina, Inc. (ILMN) Stock Price
- Profitable — net income of $850.0M in FY2025.
- Trading 8% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review ILLUMINA, INC..
Write a review
News about ILLUMINA, INC.
News & sentiment via Polygon.io
Illumina, Inc.: frequently asked questions
Is Illumina, Inc. an American company?
Yes — Illumina, Inc. is an American company. Illumina, Inc. is incorporated in Delaware, United States and headquartered in San Diego, California. Its legal-entity record reports no foreign parent — the company is independently American-owned.
Where is Illumina, Inc. incorporated?
Illumina, Inc. is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.
Who owns Illumina, Inc.?
Illumina, Inc. reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.
Is Illumina, Inc. traded on a US stock exchange?
Yes — Illumina, Inc. trades under the ticker ILMN on the NASDAQ.
Where is Illumina, Inc. headquartered?
Illumina, Inc. is headquartered in San Diego, California, United States.
Is Illumina, Inc. publicly traded?
Yes — Illumina, Inc. is a publicly traded company. Its stock trades under the ticker symbol ILMN on the NASDAQ.
What does Illumina, Inc. do?
Illumina, Inc. is an American Medical Devices company in the Health & Beauty sector.
When was Illumina, Inc. founded?
Illumina, Inc. was founded in 1998.
